MARIA VILLAFUERTE: Open Payments
NPI 1659576718 · FERNDALE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,253 in 144 payments from 18 companies in 2025. Trend: 2023 $1,461 · 2024 $2,100 · 2025 $3,253
Food & beverage: $3,229Education: $24
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 19 | $513 |
| Alkermes, Inc. | 16 | $427 |
| Teva Pharmaceuticals USA, Inc. | 13 | $359 |
| ABBVIE INC. | 10 | $333 |
| Vanda Pharmaceuticals Inc. | 13 | $271 |
| Otsuka America Pharmaceutical, Inc. | 17 | $255 |
| Janssen Pharmaceuticals, Inc | 8 | $222 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $220 |
| Supernus Pharmaceuticals, Inc. | 6 | $206 |
| E.R. Squibb & Sons, L.L.C. | 12 | $139 |
Products named: Auvelity, ARISTADA, VRAYLAR, AUSTEDO XR, FANAPT, CAPLYTA, REXULTI, Qelbree.
Industry payments across MI — which companies pay providers there.
